Eden Research plc (LON:EDEN – Get Free Report) shares were up 2.8% during trading on Tuesday after an insider bought additional shares in the company. The stock traded as high as GBX 4.18 ($0.05) and last traded at GBX 3.70 ($0.05). Approximately 12,234,783 shares changed hands during mid-day trading, an increase of 664% from the average daily volume of 1,602,016 shares. The stock had previously closed at GBX 3.60 ($0.04).
Specifically, insider Alexander John Abrey purchased 540,540 shares of the firm’s stock in a transaction on Tuesday, January 28th. The stock was bought at an average cost of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($26,902.58).
Eden Research Stock Performance
The firm’s fifty day moving average is GBX 3.88 and its 200 day moving average is GBX 4.01. The company has a current ratio of 3.80, a quick ratio of 2.42 and a debt-to-equity ratio of 1.25. The company has a market cap of £19.73 million, a PE ratio of -200.00 and a beta of 0.92.
About Eden Research
Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.
Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.
See Also
- Five stocks we like better than Eden Research
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- The Role Economic Reports Play in a Successful Investment Strategy
- What Does the Future Hold for Eli Lilly?
- What Does a Stock Split Mean?
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.
